ABT · Abbott Laboratories · Executive Compensation

$98.97 -1.98 (-1.96%)

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$174.90B

1.74B

Volume · Sep 30 3.35M Avg daily vol (3M) 9.76M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert B. Ford	Chairman of the Board and Chief Executive Officer	$1,500,000	—	$8,787,378	$8,788,430	$1,968,750	$959,798	$24,198,660
Robert Ford	Chairman of the Board and Chief Executive Officer	$1,500,000	—	$8,787,378	$8,788,430	$1,968,750	$959,798	$24,198,660
Philip Boudreau	CFO	$974,231	—	$3,045,935	$3,046,350	$1,055,400	$74,418	$9,090,636
Philip P. Boudreau	Executive Vice President, Finance and Chief Financial Officer	$974,231	—	$3,045,935	$3,046,350	$1,055,400	$74,418	$9,090,636
Lisa D. Earnhardt	Executive Vice President and Group President, Medical Devices	$924,231	—	$2,543,989	$2,544,364	$1,283,400	$178,953	$8,069,724
Hubert L. Allen	Former Executive Vice President, General Counsel and Secretary	$524,019	—	$2,095,392	$2,095,609	$447,500	$653,224	$6,995,583
Christopher J. Scoggins	Executive Vice President, Diabetes Care	$859,502	—	$1,662,503	$1,662,743	$1,095,300	$108,443	$6,601,667
Daniel G. Salvadori	Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products	$924,231	—	$2,238,786	$2,239,049	$388,200	$212,501	$6,534,285

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Ford	Chairman of the Board and Chief Executive Officer	$1,500,000	—	$8,226,593	$8,227,441	$2,861,250	$618,998	$22,777,075
Robert B. Ford	Chairman of the Board and Chief Executive Officer	$1,500,000	—	$8,226,593	$8,227,441	$2,861,250	$618,998	$22,777,075
Robert Funck	Former Executive Vice President, Finance	$535,096	—	$2,867,938	$2,868,225	$564,000	$553,057	$8,257,928
Philip P. Boudreau	Executive Vice President, Finance and Chief Financial Officer	$884,039	—	$2,693,071	$2,693,336	$1,224,700	$74,748	$8,225,746
Philip Boudreau	CFO	$884,039	—	$2,693,071	$2,693,336	$1,224,700	$74,748	$8,225,746
Hubert L. Allen	Executive Vice President, General Counsel and Secretary	$911,154	—	$2,095,365	$2,095,609	$1,094,700	$540,170	$7,981,335
Lisa D. Earnhardt	Executive Vice President and Group President, Medical Devices	$879,269	—	$2,016,528	$2,016,819	$1,249,200	$130,047	$6,558,461
Daniel G. Salvadori	Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products	$879,269	—	$1,833,239	$1,833,495	$855,400	$157,015	$5,789,762

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Ford	Chairman of the Board and Chief Executive Officer	$1,500,000	—	$7,436,600	$7,437,649	$2,945,250	$283,392	$23,268,171
Robert B. Ford	Chairman of the Board and Chief Executive Officer	$1,500,000	—	$7,436,600	$7,437,649	$2,945,250	$283,392	$23,268,171
Robert Funck	Former Executive Vice President, Finance	$875,000	—	$2,593,908	$2,594,349	$1,062,100	$238,790	$8,992,208
Hubert L. Allen	Executive Vice President, General Counsel and Secretary	$830,000	—	$1,959,639	$1,959,993	$941,700	$228,916	$7,420,660
Daniel G. Salvadori	Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products	$790,000	—	$1,880,183	$1,880,493	$880,300	$91,977	$5,934,830
Lisa D. Earnhardt	Executive Vice President and Group President, Medical Devices	$737,654	—	$1,684,197	$1,684,477	$904,900	$85,380	$5,498,436
Philip Boudreau	CFO	$513,943	—	$786,041	$786,272	$583,500	$44,083	$3,317,182
Philip P. Boudreau	Executive Vice President, Finance and Chief Financial Officer	$513,943	—	$786,041	$786,272	$583,500	$44,083	$3,317,182

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Ford	Chairman of the Board and Chief Executive Officer	$1,500,000	—	$8,699,609	$8,699,985	$2,231,250	$321,722	$21,722,152
Robert B. Ford	Chairman of the Board and Chief Executive Officer	$1,500,000	—	$8,699,609	$8,699,985	$2,231,250	$321,722	$21,722,152
Robert Funck	Former Executive Vice President, Finance	$866,154	—	$3,372,286	$3,372,494	$956,000	$341,718	$9,145,220
Daniel G. Salvadori	Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products	$790,000	—	$2,812,276	$2,812,489	$600,500	$96,812	$7,157,684
Hubert L. Allen	Executive Vice President, General Counsel and Secretary	$817,615	—	$2,396,766	$2,396,850	$871,500	$322,031	$7,019,635
Andrea F. Wainer	Executive Vice President, Rapid and Molecular Diagnostics	$710,000	—	$2,230,633	$2,230,786	$906,300	$134,662	$6,287,118

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert B. Ford	Chairman of the Board andChief Executive Officer	$1,482,692	—	$8,689,294	$8,689,978	$3,168,400	$129,179	$24,914,886
Robert Ford	Chairman of the Board andChief Executive Officer	$1,482,692	—	$8,689,294	$8,689,978	$3,168,400	$129,179	$24,914,886
Miles D. White	Former Executive Chairman of the Board	$1,900,000	—	$5,499,490	$5,499,982	$0	$1,135,477	$15,953,084
Robert Funck	Jr., Executive Vice President,Finance	$825,000	—	$2,999,666	$2,999,977	$1,048,400	$159,193	$9,539,309
Andrea F. Wainer	Executive Vice President, Rapid and Molecular Diagnostics	$699,616	—	$2,388,446	$2,388,734	$931,600	$69,112	$7,250,414
Hubert L. Allen	Executive Vice President,General Counsel andSecretary	$760,000	—	$2,115,332	$2,115,612	$921,700	$172,158	$6,853,756
Daniel G. Salvadori	Executive Vice President andGroup President, EstablishedPharmaceuticals andNutritional Products	$715,539	—	$2,388,446	$2,388,734	$925,700	$72,276	$6,742,299

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Ford	Chairman of the Board and Chief Executive Officer	$1,298,462	—	$5,623,995	$5,624,993	$3,675,000	$77,872	$20,450,586
Robert B. Ford	Chairman of the Board and Chief Executive Officer	$1,298,462	—	$5,623,995	$5,624,993	$3,675,000	$77,872	$20,450,586
Miles D. White	Former Executive Chairman of the Board	$1,900,000	—	$5,998,934	$5,999,997	$1,250,000	$1,264,110	$19,828,384
Robert Funck	Jr., Executive Vice President, Finance and Chief Financial Officer	$813,462	—	$2,215,867	$2,216,247	$1,280,800	$173,568	$9,800,209
Hubert L. Allen	Executive Vice President, General Counsel and Secretary	$751,346	—	$1,874,607	$1,874,988	$917,700	$154,596	$8,478,177
Daniel G. Salvadori	Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products	$710,000	—	$1,901,708	$1,902,099	$905,500	$79,421	$5,975,739

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Miles D. White	Former Executive Chairman of the Board	$1,900,000	—	$7,562,448	$7,562,499	$4,405,625	$664,409	$27,802,817
Robert B. Ford	Chairman of the Board and Chief Executive Officer	$1,000,000	—	$3,475,992	$3,476,054	$1,562,500	$71,841	$11,897,886
Robert Ford	Chairman of the Board and Chief Executive Officer	$1,000,000	—	$3,475,992	$3,476,054	$1,562,500	$71,841	$11,897,886
Hubert L. Allen	Executive Vice President, General Counsel and Secretary	$710,000	—	$2,199,962	$2,199,990	$879,700	$66,905	$7,486,080
Daniel G. Salvadori	Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products	$704,923	—	$2,351,989	$2,351,986	$903,400	$59,806	$6,767,814

Executive changes

Person	Role	Change	Effective	Filed
Kevin Conroy	Board of Directors	Appointed	2026-04-24	2026-04-27
Nita Ahuja, M.D.	Board of Directors	Appointed	2025-12-12	2025-12-12
Robert E. Funck, Jr.	Executive Vice President, Finance	Retired	2024-07-01	2024-05-01
Philip P. Boudreau	Senior Vice President, Finance and Chief Financial Officer	Appointed	2023-09-01	2023-06-12
John A. McCoy, Jr.	Vice President, Controller	Appointed	2023-09-01	2023-06-12
Robert E. Funck, Jr.	Executive Vice President, Finance	Appointed	2023-09-01	2023-06-12
Claire Babineaux-Fontenot	Board of Directors	Appointed	2022-09-15	2022-09-15

Key facts CIK 1800 CUSIP 002824100 13F (30d) 87 filings 37 filers Visit website